Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4546381 | 0.69 | SLC6A2 (0.34) | SLC6A2SLC6A3 | |
| SCHEMBL820768 | 0.69 | KMT2A (0.35) | — | |
| SCHEMBL21718706 | 0.67 | — | — | |
| SCHEMBL21720492 | 0.67 | — | — | |
| SCHEMBL9563995 | 0.67 | — | — | |
| SCHEMBL24191338 | 0.67 | TDO2 (0.34) | — | |
| SCHEMBL21720321 | 0.67 | — | — | |
| SCHEMBL21720117 | 0.67 | — | — | |
| SCHEMBL9608969 | 0.64 | SLC6A2 (0.45) | SLC6A2SLC6A3 | |
| SCHEMBL24498584 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9545105-B2 | 1-(heterocyclic carbonyl) piperidines | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2017-01-17 | — | — | US | disclosed |
| US-20130261155-A1 | 1-(HETEROCYCLIC CARBONYL) PIPERIDINES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-10-03 | — | — | US | disclosed |
| US-20120135975-A1 | Substituted Esters as Cannabinoid-1 Receptor Modulators | MERCK & CO., INC. (US) | 2012-05-31 | — | — | US | disclosed |
| US-20110224267-A1 | Selective androgen receptor modulators | Radius Health,Inc. (US) | 2011-09-15 | — | — | US | disclosed |
| US-20100041721-A1 | SELECTIVE ANDROGEN RECEPTOR MODULATORS | RADIUS HEALTH, INC. (US) | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130261155-A1 | 1-(HETEROCYCLIC CARBONYL) PIPERIDINES | CBR3, CBR1, CYP51A1 | SLC6A2 4838/4885SLC6A3 4536/4885 |
| US-20100041721-A1 | SELECTIVE ANDROGEN RECEPTOR MODULATORS | AR, SHBG, IGF1R | SLC6A2 4023/4885SLC6A3 4214/4885 |
| US-20110224267-A1 | Selective androgen receptor modulators | AR, SHBG, GPR119 | SLC6A2 3635/4885SLC6A3 4044/4885 |
| US-20120135975-A1 | Substituted Esters as Cannabinoid-1 Receptor Modulators | CNR1, CNR2, FAAH | SLC6A2 1390/4885SLC6A3 2186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.